The survival time after surgery for advanced liver cancer is about 0.5-1 year, because in theory, there is no indication for surgical treatment for advanced liver cancer. Of course, this surgery is mainly a radical resection surgery. Interventional embolization can be performed for advanced liver cancer. Interventional embolization is to input chemotherapeutic drugs, such as cisplatin and fluorouracil, into the tumor through the hepatic artery through the catheter, so as to kill the cancer cells and also to embolize the arteries, thus reducing the blood supply to the tumor and helping to control the tumor growth. Currently, interventional embolization therapy for advanced hepatocellular carcinoma is also a major treatment tool. Interventional embolization therapy can extend the progression-free survival time of patients from about 0.5-1 year. Therefore, the survival time after surgery for advanced liver cancer is about 0.5-1 year. Of course, it depends on the patient’s physical condition, the means of treatment, and the possibility of receiving new treatment modalities, such as immune checkpoint inhibitors or targeted therapy against tumor angiogenesis, etc.